Commonwealth Biotechnologies, Inc. to Present at the New York Society of Security Analysts; Company Seeks Improved Analyst Coverage; Newsletter Directed at Clients and Investors Also Announced.RICHMOND, Va. -- Commonwealth Biotechnologies, Inc. (CBI CBI abbr. cumulative book index CBI Confederation of British Industry CBI n abbr (= Confederation of British Industry) → C.E.O.E. ) (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CBTE), today announced that Dr. Robert B. Harris, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and Dr. Richard J. Freer, Chair and COO, have been invited to present a corporate overview Thursday, December 15 at 3:30 pm during the 2005 Specialty Pharma and Biotech conference, sponsored by the New York Society of Security Analysts (NYSSA Nyssa (nĭs`ə), name of several ancient cities devoted to the worship of Dionysus. The best known of them is a town of Cappadocia, Asia Minor, near the Halys (now the Kizil Irmak) River. It was the residence of St. Gregory of Nyssa. ), taking place at the Harvard Club in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . Dr. Harris' presentation will be available on the Company webpage at www.cbi-biotech.com a few days after December 15th. "The company is extending its investor relations program to a more public forum in order to increase analyst and investor awareness of the CBI story", said Richard J. Freer, Chairman and COO of the company. "In the past, the company has not done a very good job of making the public aware of the unique nature of the company and its position in the biotech industry. We will aggressively do so in the future and we feel this presentation to the 9,000 member NYSSA will be an important first step towards correcting that situation", he added. In addition, the company announced the planned launch of its electronic quarterly newsletter, The CBI Messenger, set for January 2006. This newsletter will seek to inform both clients and investors of the important activities ongoing at CBI. About CBI Commonwealth Biotechnologies, Inc. is a solutions provider to the global biotechnology industry, academic institutions, government agencies, and pharmaceutical companies. It offers broad ranging expertise and a complete array of the most current analytical and synthetic chemistries and biophysical analysis technologies, many of which are not available from other commercial sources. CBI has crafted a stimulating, open environment where scientists collaborate among themselves and with our clients, take on interesting challenges and develop creative solutions. Through its FIL division, CBI offers comprehensive genetic identity testing, including paternity, forensic, and CODIS CODIS Combined DNA Index System (US FBI) CODIS Convicted Offender DNA Index System CODIS Component and Distributed Systems analyses. CBI is accredited accredited recognition by an appropriate authority that the performance of a particular institution has satisfied a prestated set of criteria. accredited herds cattle herds which have achieved a low level of reactors to, e.g. by the American Association of Blood Banks, CLIA CLIA Clinical Laboratory Improvement Amendments of 1988 Congressional legislation that promulgated quality assurance practices in clinical labs, and required them to measure performance at each step of the testing process from the beginning to the end-point of a , and the National Forensic Science Technology Council, and operates fully accredited BSL-3 laboratory. For more information, visit CBI on the web at www.cbi-biotech.com and visit FIL at www.fairfaxidlab.com. Any statements contained in this release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties as identified in the Company's filings with the Securities and Exchange Commission. Actual results, events or performance may differ materially. No statement herein should be considered an offer of any securities. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion